by Premier Pharmacy Labs | Nov 10, 2015 | 503B Outsourcing, Compounding Law
Check out this nice summary by Michelle Gabriel Mcgovern published in Bloomberg BNA’s Health Care Policy Report on Sept 2014. It covers the history of 503B legislation and recent updates from the FDA regarding cGMP and guidance on bulk substances to be used in...
